RxSight, Inc.
corporate_fare Company Profile
RxSight, Inc. (NASDAQ:RXST) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 12 items for RXST at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-10, rated 7/10. Across its 12 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for RXST spans SC TO-I, 8-K, 10-Q, 10-K.
Recent high-impact activity:
- RxSight Launches Option Exchange to Retain Talent Amid Stock Slump
- RxSight Taps Aziz Mottiwala as CEO, Succeeding Founder Ron Kurtz; New Chief Lands $14M Equity Grant
- RxSight Lowers Full-Year Sales Guidance Amidst Q2 Commercial Headwinds
- RxSight Secures Major Collaboration with Alcon, Receives $60M Upfront Payment
- RxSight Lowers Full-Year Sales Guidance to $110-$120M, Citing Q2 Competitive Pressures
Financial Snapshot
Short Interest & Short Volume
5.52 days to coverFINRA reported short interest of 3,975,689 shares in RXST as of the September 15, 2026 settlement, a 2.6% increase from the prior period — about 5.5 days to cover at its recent average daily volume. On October 2, 2026, 60.5% of RXST volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.